.svg)
Advanced treatments using animals’ own cells
to support natural healing and recovery.
Cellurar
Therapies
Vetinel manufactures systems that enable veterinarians to safely extract, process, and administer cells from blood and stem cells from bone marrow or fat for autologous therapy at the point-of-care.
MORE
Healing
from within
Our technologies stimulate natural tissue regeneration, supporting repair oftendon, ligament, cartilage, bone, soft tissue, skin wounds, and breeding conditions across species. Without risk, delays, animal travel, or laboratory dependence.
MORE
function and
mobility
Biological regeneration transforms into functional recovery—restoring health, injury, strength, movement, performance, and fertility, helping animals return to work, sport, or daily life with confidence and reduced reinjury risk.
MORE
Biologics
Our fourth-generation, human-grade platforms consistently deliver high-potency autologous biologics at the point of care, using validated workflows, refined consumables, proven methodologies, and cross-species adaptability.
MORE
Protected
Always
Fully closed systems from collection to delivery, with sealed pathways, needle-free valve access, and step-specific sterile consumables—free from harmful chemicals or filters, ensuring hospital-grade safety anywhere.
MORE
Verified
Reliable
GEN4 delivers reproducible, supraphysiologic biologics sample quality—validated, high cellular yields, preserved viability and reliable potency for consistent outcomes you can trust and expect, case after case.
MORETrue regeneration leaves evidence.
Vetinél autologous biologics deliver measurable tissue repair documented through imaging, clinical follow-up, and real-world veterinary practice.
Across equine and companion animal cases, ultrasound consistently demonstrates restored tissue structure, reduced pathological defects, and re-organized functional collagen. These outcomes reflect biological healing at the source of injury, not temporary symptom control.
Engineered for precision, safety, and repeatability, Vetinél therapies perform where recovery must be proven.
Core Lesion
Clear core lesion within theSDF Tendon, with loss of tissue structure and reduced echogenicity—typical ofacute injury associated with pain, swelling, reduced performance, and high riskof reinjury if healing remains incomplete or disorganized.
MORETendon
Remodeling
Follow-up ultrasonography at 8 weeks post intra-lesional GEN4 application shows echogenic filling of the defect and re-emergence of tendon architecture - consistent with collagen deposition and structural repair, improved limb comfort and return to exercise.
MOREWhat is Vetinel® CellTech?
Vetinel® CellTech is a veterinary autologous biologics platform built on Allegene Pharmalabs’ human regenerative medicine heritage. It delivers GEN4™ closed-system consumables and workflows for consistent, point-of-care biologic preparation across species
What does “GEN4™” mean in practice?
GEN4™ representsfourth-generation biologics: fully closed systems, human-grade materials,validated centrifugation, and reproducible cellular yields—without silica,gels, or filtration artifacts.
What biologics can be prepared with Vetinel systems?
Platelet-rich concentrates (CTR™/PRP), peripheral blood stem cell–enriched fractions, bone marrow–derived concentrates (BMAC), and adipose-derived cellular fractions—depending on protocol and indication.
Are stem cells involved?
Yes. Certain Vetinel protocols enable safe point-of-care preparation of stem-cell–containing fractions (e.g. MSC-rich BMAC or adipose-derived cells), using the animal’s own tissue.
Is this compliant with field and clinic use?
GEN4™ systems are designed specifically for veterinary point-of-care use, with 100% closed processing, gamma-sterilized consumables, and workflows validated for stable, clinic, and mobile environments.
How consistent are the outcomes?
Consistency is engineered. GEN4™ systems deliver validated platelet concentration ranges, high cellular viability (>96%), and repeatable biologic quality—minimizing operator and environment variability.
Which species are supported?
Protocols are adapted and validated for equines, camelids, and companion animals, with scalable volumes and species-specific workflows.
How does Vetinel differ from standard PRP kits?
Unlike generic PRP kits, Vetinel GEN4™ systems are true concentrating platforms—human-grade, closed, filtration-free, and designed to meet regenerative thresholds rather than diluted approximations.
What is Vetinel in simple terms?
Vetine lhelps veterinarians use your animal’s own cells to support natural healing—right at the clinic or stable, without sending samples to a lab.
What kinds of problems can this help with?
Commonuses include joint issues, tendon and ligament injuries, wounds, mobilityproblems, and age-related degeneration—depending on your veterinarian’sdiagnosis.
Does this involve drugs or foreign substances?
No. Vetinel therapies are autologous, meaning they are made from your animal’s own blood or tissue, reducing the risk of rejection or incompatibility.
Is it safe for my animal?
Safety is central. Vetinel systems use hospital-grade materials and fully closed sterile processes, designed specifically for veterinary care.
Will this cure my animal?
Thesetherapies are not “miracle cures.” They are regenerative tools that support thebody’s natural repair processes and may improve comfort, function, and qualityof life.
How quickly does treatment happen?
Inmany cases, biologics are prepared and used during the same visit—withoutdelays, shipping, or additional stress for your animal.
Is this only for horses?
No. Vetinel solutions are used for horses, camels, dogs, and other companion animals, with protocols adapted to size and species.
How do I know if this is right for my animal?
Your veterinarian is the best person to advise. Vetinel provides the platform; clinical decisions remain with the treating professional.
Why is Vetinel speaking directly to riders?
Because in professional racing, performance is shared. The health of the animal and the health of the rider are inseparable. Vetinel supports the animal through veterinary biologics, while Allegene Pharmalabs supports the rider through human autologous biologics—treating both sides of the same athletic system.
What is Allegene Pharmalabs’ role for riders?
AllegenePharmalabs develops human-grade autologous biologics under its ámvyx® platform, designed to support tissue repair, recovery, and durability in professional athletes—including riders exposed to repetitive stress, impact, and injury.
What kinds of rider injuries or conditions can be addressed?
Human autologous biologics are commonly used to support recovery from:• Joint degeneration and overload (knees, hips, spine)• Tendon and ligament injuries• Muscle strains and soft-tissue trauma• Chronic inflammation from repetitive impact• Skin and tissue damage related to sun exposure and environmental stressTreatment decisions are always made by qualified medical professionals.
What does “autologous biologics” mean for me as a rider?
It means therapies prepared from your own biological material, such as blood or tissue, and used to support your body’s natural repair mechanisms—without foreign substances or donor material.
How is this different from standard sports medicine treatments?
Autologous biologics aim to address tissue quality and recovery at a biological level, rather than only masking symptoms. When appropriately indicated, they may complement rehabilitation, physiotherapy, and training programs.
Is this only for injured riders, or also for long-term wear and tear?
Many riders experience cumulative tissue stress rather than single traumatic injuries. Autologous biologics are often explored for degenerative or overuse-related conditions, where long-term durability and recovery are critical.
How does this connect to the care of my horse or camel?
Our philosophy is holistic:
• Vetinel® CellTech supports the animal using veterinary autologous biologics
• Allegene Pharmalabs / ámvyx® supports the rider using human autologous biologics.
Both are built on the same GEN4™ principles of safety, sterility, and reproducibility—applied to different patients.
What is the ultimate goal for riders using these solutions?
Notshort-term fixes, but sustainable performance. By supporting tissue health, recovery, and resilience—while ensuring the animal receives equivalent regenerative care—we aim to help rider and animal perform together, longer, and more safely.
to cummunicate